YS Biopharma Co., Ltd.

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Notice of Effectiveness

Post-effective amendment to a registration statement that is not immediately effective upon filing

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Notice of Effectiveness

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Registration statement for securities of certain foreign private issuers

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Registration statement for securities of certain foreign private issuers

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Certification by an exchange approving securities for listing

Notice of Effectiveness

Registration statement for securities issued by foreign private issuers in certain business combination transactions

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Registration statement for securities issued by foreign private issuers in certain business combination transactions

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Registration statement for securities issued by foreign private issuers in certain business combination transactions

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Registration statement for securities issued by foreign private issuers in certain business combination transactions

Prospectus filed pursuant to Rule 424(b)(3)

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Correspondence Related to Draft Registration Statement

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Correspondence Related to Draft Registration Statement

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Correspondence Related to Draft Registration Statement

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions